Automated lesion-burden tracking shows promise but is not yet validated as a clinical tool, with predictions tracking biomarkers less strongly out-of-domain than in-domain

Predictions track clinical biomarkers outside the training distribution, though less strongly than in-domain -- evidence for, not validation of, automated lesion-burden tracking as a clinical tool.

http://arxiv.org/abs/2608.27095v1